Mo Maniruzzaman

Chair & Professor @OleMissPharmacy @OleMiss; Head @PharmE3DLabs; CSO @CoM3DLtd; CSA@DosePlus Therapeutics. All views my own.

[CRS Indian Chapter @CrsIndian]

Do not forget to attend the 21st International Symposium of CRS IC in Mumbai on 24th & 25th Feb 2023 with an amazing line-up of speakers from across the globe!! See you all in the symposium @CRSScience @CRS_YSC @crs_wis
Note: On-Spot registrations are subject to availability.

[Mo Maniruzzaman @MoManiruzzaman]

So glad to see our recent publication featured on the ‘front cover’ of #ACS #Molecularpharmaceutics @ACS4Authors #MyACSCover Well done team for this great and impactful paper! @rishithakkar13 @BillTXCeutics @DannyD_PharmD @UTexasPharmacy @UTAustin #3Dprinting #innovation #SLS

[ACS Publications Bio & Med Chem Content @ACSBioMed]

Depicting the influence of a photo-opacifying agent on the degradation of the light-sensitive drug nifedipine during the selective laser sintering 3D printing process.

Congratulations Rishi Thakkar! @MoManiruzzaman @UTexasPharmacy
https://t.co/HxXhD3NMJu

[Mo Maniruzzaman @MoManiruzzaman]

It’s a privilege to collaborate with @JYYHeng @imperialcollege …@UTexasPharmacy @UTAustin

[Heng Research Group @HengGroup]

Delighted to have this opportunity to collaborate with Dr. Maniruzzaman's Lab at PharmE3D @UTexasPharmacy in establishing novel 3D printing-based manufacturing approaches. @HengGroup looking forward to working with @MoManiruzzaman! :) https://t.co/sxj95W1RWh

[Mo Maniruzzaman @MoManiruzzaman]

Well done @rishithakkar13 @DannyD_PharmD! Very #impactful #innovative and I’m sure many more to come...

[Rishi Thakkar @rishithakkar13]

Our collaborative paper on SLS #3Dprinting of amorphous solid dispersions was #featured by @JPharmSciences in their April issue. @UTexasPharmacy @DannyD_PharmD @yongchaosu @BillTXCeutics @MoManiruzzaman https://t.co/ac0YgvHHJO

[Rishi Thakkar @rishithakkar13]

Our collaborative paper on SLS #3Dprinting of amorphous solid dispersions was #featured by @JPharmSciences in their April issue. @UTexasPharmacy @DannyD_PharmD @yongchaosu @BillTXCeutics @MoManiruzzaman https://t.co/ac0YgvHHJO

[Mo Maniruzzaman @MoManiruzzaman]

Are you ready for the #3Dprinting revolution in pharmaceutical manufacturing & #drugdelivery? Please attend our hot-topic #pharmsci360 @AAPSComms #PharmE3D #MPDD @UTexasPharmacy @UTAustin @AapsChapter @pharmscitech @OleMissRebels @US_FDA @Aprecia3DP https://t.co/fzhJ90t4Bt

[Mo Maniruzzaman @MoManiruzzaman]

It’s an honour and true privilege to be on the Editorial Advisory Board of @pharmscitech @BillTXCeutics @UTexasPharmacy @UTAustin @AAPSComms @AapsChapter

[Bill Williams @BillTXCeutics]

Congratulations to @MoManiruzzaman being named to the @pharmscitech Editorial Advisory Board @AAPSComms! Outstanding scholar and scientist, thank you for your service to AAPS and the pharmaceutical sciences! @UTexasPharmacy @UTAustin

[Mo Maniruzzaman @MoManiruzzaman]

Integrated #algorithms led patient-focused #3dprinted tablets, a #QbD #DoE approach! We publish a ‘plug-and-play’ concept to optimise #dose without changing the formulations! Well done #PharmE3D #MPDD @UTexasPharmacy @UTAustin @AAPSComms @AapsChapter #AI https://t.co/rR3pGx93ip

[Mo Maniruzzaman @MoManiruzzaman]

Is #microwave induced #dielectric heating the next alternative #technology to produce #ondemand #medicine
at the point-of-care? #PharmE3D team studies this in a new article! #MDPP @UTexasPharmacy @UTAustin #personalised #drugdelivery https://t.co/XlRCkeaJ5G

[Mo Maniruzzaman @MoManiruzzaman]

Innovative solutions from #PharmE3D. Modulating #drugrelease by simply controlling print fill-density #3Dprinting. A single-step process for #personalised #medicine! #MPDD @UTexasPharmacy @UTAustin @rishithakkar13 #innovation #smartmedicine #drugdelivery https://t.co/rthsDYPOwT

[Mo Maniruzzaman @MoManiruzzaman]

So glad, our #PharmE3D Labs @UTexasPharmacy secure $720K in new funding (total $1.4M) through project #CoM3D. This will advance work on #smartpills #advancedtherapeutics #digitalhealthcare #COVID19. Way to go team! #3Dprinting #3Dbioprinting
https://t.co/j3uzsLAMON @UTAustin

[Mo Maniruzzaman @MoManiruzzaman]

What a great news! Our paper on Advanced #HME applications & #3Dprinting for personalised #drugdelivery has been selected for SI BEST PAPER award by @MDPIpharma So proud of you Deck from @SussexLifeSci! #PharmE3D #MPDD @UTexasPharmacy @UTAustin

[Mo Maniruzzaman @MoManiruzzaman]

So glad to have led #CoM3D from our #PharmE3D labs. To address critical questions on #drugdelivery, #DigitalHealth, #3Dprinting for patient focused therapy. @UTexasPharmacy @UTAustin @AapsChapter @AAPSComms

[UT Pharmacy @UTexasPharmacy]

To meet the need to develop methods to make drugs more soluble and usable, the Maniruzzaman Lab teamed up with Advanced Material Development (AMD) to address challenges with the reduction in quantity of new drugs coming to market. https://t.co/WoqARbyPbw

[Mo Maniruzzaman @MoManiruzzaman]

New paper on smart on-demand delivery of #anticancer drug. Conceptualised the work few years ago. Finally it pays off! Together we excel! @UTexasPharmacy @UTAustin #PharmE3D #3dpbio #3dprinting #smartDDs #CancerResearch @AapsChapter https://t.co/e3L8At6Z9q

[Mo Maniruzzaman @MoManiruzzaman]

@CrismonUTCOP @AACPharmacy @AAPSComms Thanks so much Dean @CrismonUTCOP for the support as always! Nasal swabs and more coming out soon! First lot is done!

[Mo Maniruzzaman @MoManiruzzaman]

We have bigger plans #PharmE3D . Way to make impact on #personalised #3Dprinting #COVID19 #drugs @UTexasPharmacy @UTAustin @AAPSComms @AapsChapter https://t.co/BkvBTz5MDV

[Mo Maniruzzaman @MoManiruzzaman]

So glad our #RAPIDShield is making an impact amid #COVIDー19 disturbance. Thanks to my #PharmE3D team, Dean @CrismonUTCOP, @BillTXCeutics without whom this wouldn’t be possible! @UTexasPharmacy @UTAustin @AAPSComms @AapsChapter

[UT Pharmacy @UTexasPharmacy]

Mo Maniruzzaman's (@MoManiruzzaman) Pharmaceutical Engineering and 3D Printing (PharmE3D) Lab is 3D-printing face shields to meet PPE demands at UT health institutions during the COVID-19 pandemic. https://t.co/rYryM9lf4s

[Mo Maniruzzaman @MoManiruzzaman]

So glad that our project from #PharmE3D #3DPBio is a WINNER of #Research4Impact competition @DellMedSchool @UTexasPharmacy @UTAustin. UT So proud of our fast growing team! #innovation #3dprinting

[Mo Maniruzzaman @MoManiruzzaman]

So privileged to have been invited as one of the plenary speakers at the prestigious @WMaterialsForum @WMFpress in June 2020, Nancy, France. #3DManufacturing: Making it Happen! #PharmE3D #3DPBio @UTexasPharmacy @UTAustin #Breakthrough #innovation
https://t.co/KdCB2ewAFN

[Mo Maniruzzaman @MoManiruzzaman]

New collaborative research paper from #PharmE3D #3DBioP Labs @UTexasPharmacy @UTAustin. It’s on next generation #LiquiPellet’ #oraldosage technology!
https://t.co/BuwBt1TNRU